McCollum Christoferson Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Hold
6,614
0.49% 44
2026
Q1
$1.62M Hold
6,614
0.49% 43
2025
Q4
$1.37M Hold
6,614
0.4% 40
2025
Q3
$1.23M Hold
6,614
0.35% 41
2025
Q2
$1.01M Sell
6,614
-100
-1% -$15.4K 0.3% 39
2025
Q1
$1.11M Sell
6,714
-195
-3% -$30.5K 0.34% 41
2024
Q4
$999K Sell
6,909
-200
-3% -$31K 0.3% 40
2024
Q3
$1.15M Sell
7,109
-45,384
-86% -$7.23M 0.33% 40
2024
Q2
$7.67M Sell
52,493
-1,071
-2% -$159K 2.28% 20
2024
Q1
$8.47M Sell
53,564
-474
-0.9% -$75.4K 2.45% 16
2023
Q4
$8.47M Sell
54,038
-404
-0.7% -$61.9K 2.56% 16
2023
Q3
$8.48M Sell
54,442
-2,238
-4% -$369K 2.61% 15
2023
Q2
$9.38M Buy
56,680
+948
+2% +$153K 2.67% 14
2023
Q1
$8.64M Sell
55,732
-431
-0.8% -$69.6K 2.66% 14
2022
Q4
$9.92M Sell
56,163
-270
-0.5% -$46.6K 3.14% 10
2022
Q3
$9.22M Sell
56,433
-607
-1% -$103K 3.08% 11
2022
Q2
$10.1M Sell
57,040
-247
-0.4% -$44K 3.09% 8
2022
Q1
$10.2M Buy
57,287
+4
+0% +$681 2.51% 11
2021
Q4
$9.8M Buy
57,283
+218
+0.4% +$35.7K 2.21% 21
2021
Q3
$9.22M Buy
57,065
+112
+0.2% +$19.1K 2.19% 20
2021
Q2
$9.38M Buy
56,953
+289
+0.5% +$47.8K 2.23% 18
2021
Q1
$9.31M Buy
56,664
+633
+1% +$102K 2.37% 18
2020
Q4
$8.82M Buy
56,031
+2,240
+4% +$331K 2.26% 17
2020
Q3
$8.01M Buy
53,791
+449
+0.8% +$66.4K 2.3% 17
2020
Q2
$7.5M Sell
53,342
-657
-1% -$95.7K 2.44% 16
2020
Q1
$7.08M Sell
53,999
-738
-1% -$105K 2.83% 8
2019
Q4
$7.98M Buy
54,737
+558
+1% +$75.7K 2.68% 11
2019
Q3
$7.01M Sell
54,179
-631
-1% -$83.1K 2.5% 15
2019
Q2
$7.63M Sell
54,810
-572
-1% -$79.2K 2.69% 12
2019
Q1
$7.74M Buy
55,382
+933
+2% +$125K 2.85% 5
2018
Q4
$7.03M Buy
54,449
+340
+0.6% +$47.4K 2.97% 5
2018
Q3
$7.48M Buy
54,109
+242
+0.4% +$32.2K 2.74% 8
2018
Q2
$6.54M Sell
53,867
-65
-0.1% -$8.11K 2.66% 9
2018
Q1
$6.91M Sell
53,932
-217
-0.4% -$29.3K 2.88% 4
2017
Q4
$7.57M Buy
+54,149
New +$7.54M 3.13% 4

Other funds holding JNJ

McCollum Christoferson Group's JNJ Position: Q2 2026 in Review

McCollum Christoferson Group held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 6,614 shares worth $1.68M. The position accounts for 0.49% of the portfolio, ranked #44.

McCollum Christoferson Group first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $10.2M in Q1 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • McCollum Christoferson Group held 6,614 shares of Johnson & Johnson worth $1.68M as of Q2 2026.
  • McCollum Christoferson Group left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.49% of McCollum Christoferson Group's portfolio in Q2 2026, its #44 holding.
  • McCollum Christoferson Group first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • McCollum Christoferson Group's Johnson & Johnson position peaked at $10.2M in Q1 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on McCollum Christoferson Group's 13F filing for Q2 2026, filed 13 Jul 2026.